Bovie Medical Corporation operates in the Medical Products industry, which could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is seeing solid activity on the earnings estimate revision front as well.
These positive earnings estimate revisions suggest that analysts are becoming more optimistic on BVX’s earnings for the coming quarter and year. In fact, consensus estimates have moved sharply higher for both of these time frames over the past four weeks, suggesting that Bovie Medical could be a solid choice for investors.
Current Quarter Estimates for BVX
In the past 30 days, 1 estimate has gone higher for Bovie Medical while none have gone lower in the same time period. The trend has been pretty favorable too, with estimates narrowing from a loss of 7 cents a share 30 days ago, to a loss of 3 cents today, a move of 57.1%.
Current Year Estimates for BVX
Meanwhile, Bovie Medical’s current year figures are also looking quite promising, with 1 estimate moving higher in the past month, compared to none lower. The consensus estimate trend has also seen a boost for this time frame, narrowing from a loss of 27 cents per share 30 days ago to a loss of 14 cents per share today, an increase of 48.1%.
Bottom Line
The stock has also started to move higher lately, adding 128.7% over the past four weeks, suggesting that investors are starting to take note of this impressive story. So investors may definitely want to consider this Zacks Rank #2 (Buy) stock to profit in the near future.
Confidential from Zacks
Beyond this Tale of the Tape, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>
Image: Bigstock
Can Bovie Medical (BVX) Run Higher on Strong Earnings Estimate Revisions?
Bovie Medical Corporation operates in the Medical Products industry, which could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is seeing solid activity on the earnings estimate revision front as well.
These positive earnings estimate revisions suggest that analysts are becoming more optimistic on BVX’s earnings for the coming quarter and year. In fact, consensus estimates have moved sharply higher for both of these time frames over the past four weeks, suggesting that Bovie Medical could be a solid choice for investors.
Current Quarter Estimates for BVX
In the past 30 days, 1 estimate has gone higher for Bovie Medical while none have gone lower in the same time period. The trend has been pretty favorable too, with estimates narrowing from a loss of 7 cents a share 30 days ago, to a loss of 3 cents today, a move of 57.1%.
Current Year Estimates for BVX
Meanwhile, Bovie Medical’s current year figures are also looking quite promising, with 1 estimate moving higher in the past month, compared to none lower. The consensus estimate trend has also seen a boost for this time frame, narrowing from a loss of 27 cents per share 30 days ago to a loss of 14 cents per share today, an increase of 48.1%.
BOVIE MEDICAL Price and Consensus
BOVIE MEDICAL Price and Consensus | BOVIE MEDICAL Quote
Bottom Line
The stock has also started to move higher lately, adding 128.7% over the past four weeks, suggesting that investors are starting to take note of this impressive story. So investors may definitely want to consider this Zacks Rank #2 (Buy) stock to profit in the near future.
Confidential from Zacks
Beyond this Tale of the Tape, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>